Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FS5ZJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $157,218
Award facts
- Contract value 100% obligated
- $157,217.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $157,217.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes, with a completion date of July 30, 2025. HEPLISAV-B is a recombinant zoster vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 and older. This delivery order represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's existing indefinite delivery vehicle with the DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts predominantly with the DLA Medical Supply Chain, supplying vaccines, pharmaceuticals, and medical devices to support Defense Health Agency operations and other federal healthcare systems. This delivery order reflects the company's continued role in fulfilling vaccine procurement requirements for the military health system.
Quick answers
Who was awarded contract SPE2DB25FS5ZJ?
SPE2DB25FS5ZJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FS5ZJ worth?
The government has obligated $157,218 on SPE2DB25FS5ZJ.
Is contract SPE2DB25FS5ZJ an order under another contract?
Yes. SPE2DB25FS5ZJ is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5ZJ competed?
The extent of competition for SPE2DB25FS5ZJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award